Ekaterina S Komarova

6PUBLICATIONS
47CO-AUTHORS
Medical infection agents (incl. prions)Biomolecular modelling and designProteins and peptidesElectrochemical energy storage and conversionMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Approaches for Studying Context Specificity of Translation Inhibitor Action.

|Mar 24, 2026
Benzoxaborole-modified azithromycins inhibit translation without inducing ermC expression.

Inna A Volynkina, Michael O Bortyazh, Chih-Wei Chen

|Dec 17, 2024
Mining Translation Inhibitors by a Unique Peptidyl-Aminonucleoside Synthetase Reveals Cystocin Biosynthesis and Self-Resistance.

Vera A Alferova, Polina A Zotova, Anna A Baranova

|Oct 27, 2022
Flow-Seq Evaluation of Translation Driven by a Set of Natural Escherichia coli 5'-UTR of Variable Length.

Ekaterina S Komarova, Anna N Slesarchuk, Maria P Rubtsova

|Jul 01, 2020
Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel.

Ilya A Osterman, Maximiliane Wieland, Tinashe P Maviza

|Mar 31, 2018
Biosynthesis of Translation Inhibitor Klebsazolicin Proceeds through Heterocyclization and N-Terminal Amidine Formation Catalyzed by a Single YcaO Enzyme.

Dmitrii Y Travin, Mikhail Metelev, Marina Serebryakova

Pageof 1